S2 Ep59: Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC
- Author
- Pharmacy Times
- Published
- Wed 30 Jul 2025
- Episode Link
- https://audioboom.com/posts/8756542
Kevin Chen, PharmD, MS, BCOP, CPP, and Amanda Cass, PharmD, BCPS, BCOP, share key insights about ROS1, non-small cell lung cancer, and the new approved drug taletrectinib.
